Here are four things to know.
1. Levetiracetam is intended to treat partial onset seizures related to epilepsy.
2. The tablets are a generic equivalent to UCB’s brand name drug Keppra XR.
3. Sales of sales Keppra XR and all other generic equivalents already on the market in the U.S. reached about $168 million for the 12 months ended December 2015, according to Symphony Health Solutions.
4. Intellipharmaceutics has eight other new drug applications pending FDA review.
More articles on supply chain:
6 must-reads for supply chain leaders this week
UPS to offer Saturday ground delivery services
FDA approves new liquid drug for hypothyroidism
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
